Bone marrow mesenchymal stem cell transplantation for children with severe osteogenesis imperfecta

Genetic Engineering of Mesenchymal Stem Cells

Volumn , Issue , 2006, Pages 135-150

  Horwitz, E M ^a   Gordon, P L ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84859486674     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/1-4020-3959-X_8     Document Type: Chapter

References (42)

1. Thomas ED, Lochte HL, Lu WC, Ferrebee JW. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med. 1957:257:491-496.
2. Urso P, Congdon CC. The effect of the amount of isologous bone marrow injected on the recovery of hematopoietic organs, survival and body weight after lethal irradiation injury in mice. Blood. 1957;12:251-260.
3. Crouch BG, Overman RR. Whole-body radiation protection in primates. Federation Proc. 1957;27.
4. Ford CE, Hamerton JL, Barnes DWH, Loutit JF. Cytological identification of radiation-chimaeras. Nature. October 3, 1956;177:452-454.
5. Civin CI, Strauss LC, Brovall C, et al. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol. 1984;133:157-165.
6. Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation. 1968;6:230-247.
7. Friedenstein AJ, Gorskaja UF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol. 1976;4:267-274.
8. Friedenstein AJ, Latzinik NV, Gorskaya Y, Luria EA, Moskvina IL. Bone marrow stromal colony formation requires stimulation by haemopoietic cells. Bone Miner. 1992;18:199-213.
9. Friedenstein AJ, Ivanov-Smolenski AA, Chajlakjan RK, et al. Origin of bone marrowstromal mechanocytes in radiochimeras and heterotopic transplants. Exp Hematol. 1978;6:440-444.
10. Friedenstein AJ, Deriglasova UF, Kulagina NN, et al. Precursors for fibroblasts in different populations of hematopoietic cells as detected by thein vitro colony assay method. Exp Hematol. 1974;2:83-92.
11. Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF, Keiliss-Borok IV. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation. 1974;17:331-340.
12. Till JE, McCulloch EA. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res. 1961;14:213-222.
13. Owen M. Lineage of osteogenic cells and their relationship to the stromal system. In: Peck W, ed. J Bone Min Res. Vol 3. Elsevier; 1985:1-25.
14. Owen M, Friedenstein AJ. Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp. 1988;136:42-60.
15. Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991;9:641-650.
16. Pereira RF, Halford KW, O'Hara MD, et al. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci USA. 1995;92:4857-4861.
17. Byers PH. Disorders of collagen biosynthesis and structure. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of InheritedDisease. NewYork, NY: McGraw-Hill; 1995:4029-4077.
18. Sillence DO. Disorders of bone density, volume, and mineralization. In: Rimoin DL, Connor JM, Pyeritz RE, eds. Emery and Rimoin's Principles and Practice of Medical Genetics. 3rd ed., Vol 2. New York, NY: Churchill Livingstone; 1997.
19. Lazarus HM, Haynesworth SE, Gerson SL, Rosenthal NS, Caplan AI. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant. 1995;16:557-564.
20. Horwitz EM, Keating A. Nonhematopoietic mesenchymal stem cells: what are they? Cytotherapy. 2000;2:387-388.
21. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143-147.
22. Long MW, Robinson JA, Ashcraft EA, Mann KG. Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors [published erratum appears in JClin Invest. 1995;96(5):2541]. J Clin Invest. 1995;95:881-887.
23. Long MW, Williams JL, Mann KG. Expression of human bone-related proteins in the hematopoietic microenvironment. J Clin Invest. 1990;86:1387-1395.
24. Colter DC, Class R, Digirolamo CM, Prockop DJ. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA. 2000;97:3213-3218.
25. Colter DC, Sekiya I, Prockop DJ. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci USA. 2001;98:7841-7845.
26. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418:41-49.
27. Olmsted-Davis EA, Gugala Z, Camargo F, et al. Primitive adult hematopoietic stem cells can function as osteoblast precursors. Proc Natl Acad Sci USA. 2003;100:15877-15882.
28. Constantinou CO, Pack M, Young S, Prockop DJ. Phenotypic heterogeneity in osteogeneisi imperfecta: the mildly affected mother of a proband with a lethal variant has the same mutation substituting cysteine for a1-glycine 904 in a type I procollagen gene (COL1A1). Am J Hum Genet. 1990;47:670-679.
29. Sokolov BP, Mays P, Khillan J, Prockop DJ. Tissue- and development specific expression in transgenic mice of a type I procollagen (COL1A1) minigene construct with 2.3 kb of the promoter region of 2 kb of the 3' flanking region. Specificty is independent of the putative regulatory sequences in the first intron. Biochemistry. 1993;32:9242-9249.
30. Pereira RF, O'Hara MD, Laptev A, et al. Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc Natl Acad Sci USA. 1998;95:1142-1147.
31. Horwitz EM, Prockop DJ, Fitzpatrick LA, et al. Transplantability and therapeutic effects of bone marrowderived mesenchymal cells in children with osteogenesis imperfecta. Nat Med. 1999;5:309-313.
32. Horwitz EM, Gordon PL, Koo WKK, et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA. 2000;99(13):8932-8937.
33. Brenner MK, Rill DR, Moen RC, et al. Gene-marking to trace origin of relapse after autologous bonemarrow transplantation. Lancet. 1993;341:85-86.
34. Robey PG, Termine JD. Human bone cells in vitro. Calcif Tissue Int. 1985;37:453-460.
35. Van Der PA, Aarden EM, Feijen JH, et al. Characteristics and properties of osteocytes in culture. J Bone Miner Res. 1994;9:1697-1704.
36. Banfi A, Muraglia A, Dozin B, et al. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy. Exp Hematol. 2000;28:707-715.
37. Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol. 2002;30:42-48.
38. Kleeberger W, Versmold A, Rothamel T, et al. Increased chimerism of bronchial and alveolar epithelium in human lung allografts undergoing chronic injury. Am J Pathol. 2003;162:1487-1494.
39. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringden O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol. 2003;57:11-20.
40. Whyte MP, Kurtzberg J, McAlister WH, et al. Marrow cell transplantation for infantile hypophosphatasia. J Bone Miner Res. 2003;18:624-636.
41. Gronthos S, Simmons PJ. The growth factor requirements of STRO-1-positive human bone marrowstromal precursors under serum-deprived conditions in vitro. Blood. 1995;85:929-940.
42. Gregory CA, Singh H, Perry AS, Prockop DJ. The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow. J Biol Chem. 2003;278:28067-28078